Health
New comparative performance data published for authorized COVID-19 molecular diagnostic tests – News-Medical.Net
Today, the U.S. Food and Drug Administration published comparative performance data for some authorized COVID-19 molecular diagnostic tests.
Reviewed by Emily Henderson, B.Sc.Sep 16 2020
Today, the U.S. Food and Drug Administration published comparative performance data for some authorized COVID-19 molecular diagnostic tests. The tables show the Limit of Detection (LoD) of more than 55 authorized molecular diagnostic COVID-19 tests against a standardized sample panel provided by the FDA.
The FDA provided these standardized samples, known as a reference panel, to test developers who are required to assess their test’s performance ag…
-
General16 hours agoWe’ve all talked about potential economic consequences for Australia of Trump’s policies. Now they’re happening
-
General13 hours agoStephanie Scott’s murder caused a ‘seismic’ shock in Leeton, and the hurt remains
-
Noosa News23 hours agoBrisbane doctor jailed for trafficking ‘breathtaking amount’ of drugs
-
Noosa News16 hours ago’Lethal new opioids’ prompt Wide Bay pill testing call